Michelle Barton
Adult Health · Fayetteville, NCNPI 1497807309
Payments from drug & device makers
Across 64 payments — averaging $25.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$508
- Sun Pharmaceutical Industries Inc.$496
- Pfizer$225
- AbbVie$98
- Dermavant Sciences, Inc.$72
- Novartis$62
- plus $156 from 7 others
What the payments were for
- Food & beverage$1,02563%
- Education$59237%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 10 | $508 |
| Sun Pharmaceutical Industries Inc. | 18 | $496 |
| Pfizer | 17 | $225 |
| AbbVie | 5 | $98 |
| Dermavant Sciences, Inc. | 4 | $72 |
| Novartis | 3 | $62 |
| Incyte Corporation | 1 | $54 |
| GSK | 1 | $26 |
| Calliditas Therapeutics US Inc. | 1 | $24 |
| LEO Pharma Inc. | 1 | $18 |
| Kerecis Limited | 1 | $14 |
| Almirall LLC | 1 | $12 |
| Organon | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ILUMYA$121
How this compares
$1,617 in reported general payments places this provider in the 75th percentile of 614 adult health providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OtezlaApremilast | 13 | $59,727 |
| Clobetasol Propionate | 41 | $2,130 |
| Fluorouracil | 36 | $2,021 |
| Azelaic Acid | 14 | $1,771 |
| Mupirocin | 141 | $970 |
| Triamcinolone Acetonide | 59 | $613 |
| Ketoconazole | 31 | $593 |
| Doxycycline Hyclate | 31 | $236 |
| Clindamycin Phosphate | 14 | $223 |
| Hydrocortisone | 16 | $136 |
| Cephalexin | 15 | $37 |
| Prednisone | 13 | $6 |
Paid to pharmacies, not to this prescriber.
Other adult health in Fayetteville
- Shannon SnyderFayetteville$6K
- Robert DodgeRaleigh$311K
- Kimberly CampDurham$147K
- Henry VanpalaRaleigh$110K
- Jolene SpencerWashington$83K
- Felicia RichardsonGreenville$64K
- Anna BooneReidsville$51K
- Chaely MedleyChapel Hill$47K
- Ann ShumDurham$35K
- Amy HopkinsGreenville$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.